Tissue Diagnostics Instrument Market, Global Outlook and Forecast 2022-2028
Report Code: KNJ1281652 No. of Pages: 121 Category: Medical Devices
Publisher: Date of Publish:
Publisher: Date of Publish:
This report contains market size and forecasts of Tissue Diagnostics Instrument in global, including the following market information:
Global Tissue Diagnostics Instrument Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Tissue Diagnostics Instrument Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Tissue Diagnostics Instrument companies in 2021 (%)
The global Tissue Diagnostics Instrument market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Slide-staining Systems Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Tissue Diagnostics Instrument include Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott (US), Agilent Technologies (US), Merck (Germany), Sakura Finetek Japan (Japan), Abcam (UK) and BD (US), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tissue Diagnostics Instrument manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tissue Diagnostics Instrument Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Tissue Diagnostics Instrument Market Segment Percentages, by Type, 2021 (%)
Slide-staining Systems
Scanners
Tissue-processing Systems
Others
Global Tissue Diagnostics Instrument Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Tissue Diagnostics Instrument Market Segment Percentages, by Application, 2021 (%)
Breast Cancer
Gastric Cancer
Lymphoma
Prostate Cancer
Non-small Cell Lung Cancer
Others
Global Tissue Diagnostics Instrument Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Tissue Diagnostics Instrument Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tissue Diagnostics Instrument revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Tissue Diagnostics Instrument revenues share in global market, 2021 (%)
Key companies Tissue Diagnostics Instrument sales in global market, 2017-2022 (Estimated), (Units)
Key companies Tissue Diagnostics Instrument sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche (Switzerland)
Danaher (US)
Thermo Fisher Scientific (US)
Abbott (US)
Agilent Technologies (US)
Merck (Germany)
Sakura Finetek Japan (Japan)
Abcam (UK)
BD (US)
QIAGEN (Netherlands)
Sienna Cancer Diagnostics (Australia)
Royal Philips (Netherlands)
A. Menarini Diagnostics (Italy)
Cell Signaling Technology (US)
Enzo Life Sciences (US)
Master Diagnóstica (Spain)
TissueGnostics (Austria)
Bio SB (US)
MedImmune (US)
Cernostics (US)
1 Introduction to Research & Analysis Reports
1.1 Tissue Diagnostics Instrument Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tissue Diagnostics Instrument Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tissue Diagnostics Instrument Overall Market Size
2.1 Global Tissue Diagnostics Instrument Market Size: 2021 VS 2028
2.2 Global Tissue Diagnostics Instrument Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Tissue Diagnostics Instrument Sales: 2017-2028
3 Company Landscape
3.1 Top Tissue Diagnostics Instrument Players in Global Market
3.2 Top Global Tissue Diagnostics Instrument Companies Ranked by Revenue
3.3 Global Tissue Diagnostics Instrument Revenue by Companies
3.4 Global Tissue Diagnostics Instrument Sales by Companies
3.5 Global Tissue Diagnostics Instrument Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Tissue Diagnostics Instrument Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Tissue Diagnostics Instrument Product Type
3.8 Tier 1, Tier 2 and Tier 3 Tissue Diagnostics Instrument Players in Global Market
3.8.1 List of Global Tier 1 Tissue Diagnostics Instrument Companies
3.8.2 List of Global Tier 2 and Tier 3 Tissue Diagnostics Instrument Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Tissue Diagnostics Instrument Market Size Markets, 2021 & 2028
4.1.2 Slide-staining Systems
4.1.3 Scanners
4.1.4 Tissue-processing Systems
4.1.5 Others
4.2 By Type - Global Tissue Diagnostics Instrument Revenue & Forecasts
4.2.1 By Type - Global Tissue Diagnostics Instrument Revenue, 2017-2022
4.2.2 By Type - Global Tissue Diagnostics Instrument Revenue, 2023-2028
4.2.3 By Type - Global Tissue Diagnostics Instrument Revenue Market Share, 2017-2028
4.3 By Type - Global Tissue Diagnostics Instrument Sales & Forecasts
4.3.1 By Type - Global Tissue Diagnostics Instrument Sales, 2017-2022
4.3.2 By Type - Global Tissue Diagnostics Instrument Sales, 2023-2028
4.3.3 By Type - Global Tissue Diagnostics Instrument Sales Market Share, 2017-2028
4.4 By Type - Global Tissue Diagnostics Instrument Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Tissue Diagnostics Instrument Market Size, 2021 & 2028
5.1.2 Breast Cancer
5.1.3 Gastric Cancer
5.1.4 Lymphoma
5.1.5 Prostate Cancer
5.1.6 Non-small Cell Lung Cancer
5.1.7 Others
5.2 By Application - Global Tissue Diagnostics Instrument Revenue & Forecasts
5.2.1 By Application - Global Tissue Diagnostics Instrument Revenue, 2017-2022
5.2.2 By Application - Global Tissue Diagnostics Instrument Revenue, 2023-2028
5.2.3 By Application - Global Tissue Diagnostics Instrument Revenue Market Share, 2017-2028
5.3 By Application - Global Tissue Diagnostics Instrument Sales & Forecasts
5.3.1 By Application - Global Tissue Diagnostics Instrument Sales, 2017-2022
5.3.2 By Application - Global Tissue Diagnostics Instrument Sales, 2023-2028
5.3.3 By Application - Global Tissue Diagnostics Instrument Sales Market Share, 2017-2028
5.4 By Application - Global Tissue Diagnostics Instrument Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Tissue Diagnostics Instrument Market Size, 2021 & 2028
6.2 By Region - Global Tissue Diagnostics Instrument Revenue & Forecasts
6.2.1 By Region - Global Tissue Diagnostics Instrument Revenue, 2017-2022
6.2.2 By Region - Global Tissue Diagnostics Instrument Revenue, 2023-2028
6.2.3 By Region - Global Tissue Diagnostics Instrument Revenue Market Share, 2017-2028
6.3 By Region - Global Tissue Diagnostics Instrument Sales & Forecasts
6.3.1 By Region - Global Tissue Diagnostics Instrument Sales, 2017-2022
6.3.2 By Region - Global Tissue Diagnostics Instrument Sales, 2023-2028
6.3.3 By Region - Global Tissue Diagnostics Instrument Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Tissue Diagnostics Instrument Revenue, 2017-2028
6.4.2 By Country - North America Tissue Diagnostics Instrument Sales, 2017-2028
6.4.3 US Tissue Diagnostics Instrument Market Size, 2017-2028
6.4.4 Canada Tissue Diagnostics Instrument Market Size, 2017-2028
6.4.5 Mexico Tissue Diagnostics Instrument Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Tissue Diagnostics Instrument Revenue, 2017-2028
6.5.2 By Country - Europe Tissue Diagnostics Instrument Sales, 2017-2028
6.5.3 Germany Tissue Diagnostics Instrument Market Size, 2017-2028
6.5.4 France Tissue Diagnostics Instrument Market Size, 2017-2028
6.5.5 U.K. Tissue Diagnostics Instrument Market Size, 2017-2028
6.5.6 Italy Tissue Diagnostics Instrument Market Size, 2017-2028
6.5.7 Russia Tissue Diagnostics Instrument Market Size, 2017-2028
6.5.8 Nordic Countries Tissue Diagnostics Instrument Market Size, 2017-2028
6.5.9 Benelux Tissue Diagnostics Instrument Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Tissue Diagnostics Instrument Revenue, 2017-2028
6.6.2 By Region - Asia Tissue Diagnostics Instrument Sales, 2017-2028
6.6.3 China Tissue Diagnostics Instrument Market Size, 2017-2028
6.6.4 Japan Tissue Diagnostics Instrument Market Size, 2017-2028
6.6.5 South Korea Tissue Diagnostics Instrument Market Size, 2017-2028
6.6.6 Southeast Asia Tissue Diagnostics Instrument Market Size, 2017-2028
6.6.7 India Tissue Diagnostics Instrument Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Tissue Diagnostics Instrument Revenue, 2017-2028
6.7.2 By Country - South America Tissue Diagnostics Instrument Sales, 2017-2028
6.7.3 Brazil Tissue Diagnostics Instrument Market Size, 2017-2028
6.7.4 Argentina Tissue Diagnostics Instrument Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Tissue Diagnostics Instrument Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Tissue Diagnostics Instrument Sales, 2017-2028
6.8.3 Turkey Tissue Diagnostics Instrument Market Size, 2017-2028
6.8.4 Israel Tissue Diagnostics Instrument Market Size, 2017-2028
6.8.5 Saudi Arabia Tissue Diagnostics Instrument Market Size, 2017-2028
6.8.6 UAE Tissue Diagnostics Instrument Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Roche (Switzerland)
7.1.1 Roche (Switzerland) Corporate Summary
7.1.2 Roche (Switzerland) Business Overview
7.1.3 Roche (Switzerland) Tissue Diagnostics Instrument Major Product Offerings
7.1.4 Roche (Switzerland) Tissue Diagnostics Instrument Sales and Revenue in Global (2017-2022)
7.1.5 Roche (Switzerland) Key News
7.2 Danaher (US)
7.2.1 Danaher (US) Corporate Summary
7.2.2 Danaher (US) Business Overview
7.2.3 Danaher (US) Tissue Diagnostics Instrument Major Product Offerings
7.2.4 Danaher (US) Tissue Diagnostics Instrument Sales and Revenue in Global (2017-2022)
7.2.5 Danaher (US) Key News
7.3 Thermo Fisher Scientific (US)
7.3.1 Thermo Fisher Scientific (US) Corporate Summary
7.3.2 Thermo Fisher Scientific (US) Business Overview
7.3.3 Thermo Fisher Scientific (US) Tissue Diagnostics Instrument Major Product Offerings
7.3.4 Thermo Fisher Scientific (US) Tissue Diagnostics Instrument Sales and Revenue in Global (2017-2022)
7.3.5 Thermo Fisher Scientific (US) Key News
7.4 Abbott (US)
7.4.1 Abbott (US) Corporate Summary
7.4.2 Abbott (US) Business Overview
7.4.3 Abbott (US) Tissue Diagnostics Instrument Major Product Offerings
7.4.4 Abbott (US) Tissue Diagnostics Instrument Sales and Revenue in Global (2017-2022)
7.4.5 Abbott (US) Key News
7.5 Agilent Technologies (US)
7.5.1 Agilent Technologies (US) Corporate Summary
7.5.2 Agilent Technologies (US) Business Overview
7.5.3 Agilent Technologies (US) Tissue Diagnostics Instrument Major Product Offerings
7.5.4 Agilent Technologies (US) Tissue Diagnostics Instrument Sales and Revenue in Global (2017-2022)
7.5.5 Agilent Technologies (US) Key News
7.6 Merck (Germany)
7.6.1 Merck (Germany) Corporate Summary
7.6.2 Merck (Germany) Business Overview
7.6.3 Merck (Germany) Tissue Diagnostics Instrument Major Product Offerings
7.6.4 Merck (Germany) Tissue Diagnostics Instrument Sales and Revenue in Global (2017-2022)
7.6.5 Merck (Germany) Key News
7.7 Sakura Finetek Japan (Japan)
7.7.1 Sakura Finetek Japan (Japan) Corporate Summary
7.7.2 Sakura Finetek Japan (Japan) Business Overview
7.7.3 Sakura Finetek Japan (Japan) Tissue Diagnostics Instrument Major Product Offerings
7.7.4 Sakura Finetek Japan (Japan) Tissue Diagnostics Instrument Sales and Revenue in Global (2017-2022)
7.7.5 Sakura Finetek Japan (Japan) Key News
7.8 Abcam (UK)
7.8.1 Abcam (UK) Corporate Summary
7.8.2 Abcam (UK) Business Overview
7.8.3 Abcam (UK) Tissue Diagnostics Instrument Major Product Offerings
7.8.4 Abcam (UK) Tissue Diagnostics Instrument Sales and Revenue in Global (2017-2022)
7.8.5 Abcam (UK) Key News
7.9 BD (US)
7.9.1 BD (US) Corporate Summary
7.9.2 BD (US) Business Overview
7.9.3 BD (US) Tissue Diagnostics Instrument Major Product Offerings
7.9.4 BD (US) Tissue Diagnostics Instrument Sales and Revenue in Global (2017-2022)
7.9.5 BD (US) Key News
7.10 QIAGEN (Netherlands)
7.10.1 QIAGEN (Netherlands) Corporate Summary
7.10.2 QIAGEN (Netherlands) Business Overview
7.10.3 QIAGEN (Netherlands) Tissue Diagnostics Instrument Major Product Offerings
7.10.4 QIAGEN (Netherlands) Tissue Diagnostics Instrument Sales and Revenue in Global (2017-2022)
7.10.5 QIAGEN (Netherlands) Key News
7.11 Sienna Cancer Diagnostics (Australia)
7.11.1 Sienna Cancer Diagnostics (Australia) Corporate Summary
7.11.2 Sienna Cancer Diagnostics (Australia) Tissue Diagnostics Instrument Business Overview
7.11.3 Sienna Cancer Diagnostics (Australia) Tissue Diagnostics Instrument Major Product Offerings
7.11.4 Sienna Cancer Diagnostics (Australia) Tissue Diagnostics Instrument Sales and Revenue in Global (2017-2022)
7.11.5 Sienna Cancer Diagnostics (Australia) Key News
7.12 Royal Philips (Netherlands)
7.12.1 Royal Philips (Netherlands) Corporate Summary
7.12.2 Royal Philips (Netherlands) Tissue Diagnostics Instrument Business Overview
7.12.3 Royal Philips (Netherlands) Tissue Diagnostics Instrument Major Product Offerings
7.12.4 Royal Philips (Netherlands) Tissue Diagnostics Instrument Sales and Revenue in Global (2017-2022)
7.12.5 Royal Philips (Netherlands) Key News
7.13 A. Menarini Diagnostics (Italy)
7.13.1 A. Menarini Diagnostics (Italy) Corporate Summary
7.13.2 A. Menarini Diagnostics (Italy) Tissue Diagnostics Instrument Business Overview
7.13.3 A. Menarini Diagnostics (Italy) Tissue Diagnostics Instrument Major Product Offerings
7.13.4 A. Menarini Diagnostics (Italy) Tissue Diagnostics Instrument Sales and Revenue in Global (2017-2022)
7.13.5 A. Menarini Diagnostics (Italy) Key News
7.14 Cell Signaling Technology (US)
7.14.1 Cell Signaling Technology (US) Corporate Summary
7.14.2 Cell Signaling Technology (US) Business Overview
7.14.3 Cell Signaling Technology (US) Tissue Diagnostics Instrument Major Product Offerings
7.14.4 Cell Signaling Technology (US) Tissue Diagnostics Instrument Sales and Revenue in Global (2017-2022)
7.14.5 Cell Signaling Technology (US) Key News
7.15 Enzo Life Sciences (US)
7.15.1 Enzo Life Sciences (US) Corporate Summary
7.15.2 Enzo Life Sciences (US) Business Overview
7.15.3 Enzo Life Sciences (US) Tissue Diagnostics Instrument Major Product Offerings
7.15.4 Enzo Life Sciences (US) Tissue Diagnostics Instrument Sales and Revenue in Global (2017-2022)
7.15.5 Enzo Life Sciences (US) Key News
7.16 Master Diagnóstica (Spain)
7.16.1 Master Diagnóstica (Spain) Corporate Summary
7.16.2 Master Diagnóstica (Spain) Business Overview
7.16.3 Master Diagnóstica (Spain) Tissue Diagnostics Instrument Major Product Offerings
7.16.4 Master Diagnóstica (Spain) Tissue Diagnostics Instrument Sales and Revenue in Global (2017-2022)
7.16.5 Master Diagnóstica (Spain) Key News
7.17 TissueGnostics (Austria)
7.17.1 TissueGnostics (Austria) Corporate Summary
7.17.2 TissueGnostics (Austria) Business Overview
7.17.3 TissueGnostics (Austria) Tissue Diagnostics Instrument Major Product Offerings
7.17.4 TissueGnostics (Austria) Tissue Diagnostics Instrument Sales and Revenue in Global (2017-2022)
7.17.5 TissueGnostics (Austria) Key News
7.18 Bio SB (US)
7.18.1 Bio SB (US) Corporate Summary
7.18.2 Bio SB (US) Business Overview
7.18.3 Bio SB (US) Tissue Diagnostics Instrument Major Product Offerings
7.18.4 Bio SB (US) Tissue Diagnostics Instrument Sales and Revenue in Global (2017-2022)
7.18.5 Bio SB (US) Key News
7.19 MedImmune (US)
7.19.1 MedImmune (US) Corporate Summary
7.19.2 MedImmune (US) Business Overview
7.19.3 MedImmune (US) Tissue Diagnostics Instrument Major Product Offerings
7.19.4 MedImmune (US) Tissue Diagnostics Instrument Sales and Revenue in Global (2017-2022)
7.19.5 MedImmune (US) Key News
7.20 Cernostics (US)
7.20.1 Cernostics (US) Corporate Summary
7.20.2 Cernostics (US) Business Overview
7.20.3 Cernostics (US) Tissue Diagnostics Instrument Major Product Offerings
7.20.4 Cernostics (US) Tissue Diagnostics Instrument Sales and Revenue in Global (2017-2022)
7.20.5 Cernostics (US) Key News
8 Global Tissue Diagnostics Instrument Production Capacity, Analysis
8.1 Global Tissue Diagnostics Instrument Production Capacity, 2017-2028
8.2 Tissue Diagnostics Instrument Production Capacity of Key Manufacturers in Global Market
8.3 Global Tissue Diagnostics Instrument Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Tissue Diagnostics Instrument Supply Chain Analysis
10.1 Tissue Diagnostics Instrument Industry Value Chain
10.2 Tissue Diagnostics Instrument Upstream Market
10.3 Tissue Diagnostics Instrument Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Tissue Diagnostics Instrument Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com